<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>dual to triple therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/dual-to-triple-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 04:39:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>dual to triple therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>COPD Treatment: Impact of Dual Therapy on Outcomes</title>
		<link>https://bioengineer.org/copd-treatment-impact-of-dual-therapy-on-outcomes/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 04:38:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[dual to triple therapy]]></category>
		<category><![CDATA[exacerbation-based therapy]]></category>
		<category><![CDATA[FF/UMEC/VI vs BUD/GLY/FORM]]></category>
		<category><![CDATA[here are 5 appropriate tags: **COPD treatment escalation]]></category>
		<guid isPermaLink="false">https://bioengineer.org/copd-treatment-impact-of-dual-therapy-on-outcomes/</guid>

					<description><![CDATA[In a groundbreaking study published in Advances in Therapy, researchers have delved deep into the comparative effectiveness of different treatment regimens for patients with Chronic Obstructive Pulmonary Disease (COPD). The study titled “FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318722</post-id>	</item>
	</channel>
</rss>
